More recently, it was suggested that the degree of drug-induced ERS aggravation correlates with MUC2 expression levels and that high mucin-producing cells are more susceptible to drug-mediated ERS aggravation (Dilly et al., 2020). Here, MUC5AC is linked to amelogenesis imperfecta type 1G.